Literature DB >> 12821623

Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy?

Daniel G Hackam1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821623      PMCID: PMC161615     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

Authors:  S Yusuf; S Reddy; S Ounpuu; S Anand
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

2.  Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

Authors:  G L Knatterud; Y Rosenberg; L Campeau; N L Geller; D B Hunninghake; S A Forman; J S Forrester; F L Gobel; J A Herd; A Hickey; B J Hoogwerf; M L Terrin; C White
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

3.  Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Authors:  Vasilios G Athyros; Athanasios A Papageorgiou; Bodosakis R Mercouris; Valasia V Athyrou; Athanasios N Symeonidis; Elias O Basayannis; Dimokritos S Demitriadis; Athanasios G Kontopoulos
Journal:  Curr Med Res Opin       Date:  2002       Impact factor: 2.580

4.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

  4 in total
  1 in total

1.  No absolutes.

Authors:  Anthony T Kerrigan
Journal:  CMAJ       Date:  2003-09-30       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.